Compare Merck & Co., Inc. (MRK) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Advanced Drainage Systems Inc — how do they compare? Merck & Co., Inc. trades at $126.24 (market cap $307.25B), while Advanced Drainage Systems Inc trades at $143.04 (market cap $10.96B). The key difference: Merck & Co., Inc. is far larger — about 28× Advanced Drainage Systems Inc's market cap, and Merck & Co., Inc. pays the higher dividend (2.73%). Which is the better fit depends on your goals.
| MRK | WMS | |
|---|---|---|
Market Cap | $307.25B | $10.96B |
Sector | Health | Industrials |
52-Week High | $129.52 | $175.38 |
52-Week Low | $77.60 | $110.99 |
Enterprise Value | $350.66B | $12.53B |
Dividend Yield | 2.73% | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $126.27, down 0.96% on the day, with a neutral technical signal and strong fundamental performance. The company reported robust 2025 results with $65.01B revenue and $18.25B net income, beating EPS estimates in recent quarters. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while analyst consensus remains bullish with a $137.30 price target.
Outlook is positive driven by earnings momentum and strategic M&A, but risks include patent expirations and competitive pressures. The stock offers a dividend yield with upcoming payment, supporting income investors. Valuation multiples are elevated, requiring sustained growth to justify current levels amid macroeconomic uncertainties.
WMS (Advanced Drainage Systems) trades at $138.74, down 5.97% on the day, with a bearish technical signal. The company shows solid fundamentals with a 13.98% net income margin and consistent earnings beats in recent quarters, though 2025 revenue was flat at $2.90B. Recent news includes a dividend increase and upcoming Q1 FY2027 results on August 6, 2026.
The stock presents a mixed outlook. Strong profitability and a consensus price target of $184.43 suggest upside potential, but near-term headwinds include a bearish technical setup and projected earnings decline in 2026. Key risks are execution on investments and competitive pressures in the water management sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
